BLACKROCK HEALTH SCIENCES TR's ticker is BME and the CUSIP is 09250W107. A total of 60 filers reported holding BLACKROCK HEALTH SCIENCES TR in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $128,804 | -3.7% | 3,290 | 0.0% | 0.03% | +3.2% |
| Q2 2023 | $133,706 | -31.2% | 3,290 | -29.1% | 0.03% | -35.4% |
| Q1 2023 | $194,230 | -3.9% | 4,640 | 0.0% | 0.05% | -11.1% |
| Q4 2022 | $202,211 | +12.3% | 4,640 | 0.0% | 0.05% | 0.0% |
| Q3 2022 | $180,000 | -8.2% | 4,640 | 0.0% | 0.05% | -6.9% |
| Q2 2022 | $196,000 | -7.1% | 4,640 | 0.0% | 0.06% | +13.7% |
| Q1 2022 | $211,000 | -6.6% | 4,640 | -0.3% | 0.05% | -7.3% |
| Q4 2021 | $226,000 | -2.6% | 4,654 | -4.4% | 0.06% | -6.8% |
| Q3 2021 | $232,000 | -1.7% | 4,869 | 0.0% | 0.06% | -3.3% |
| Q2 2021 | $236,000 | +4.4% | 4,869 | -0.6% | 0.06% | -3.2% |
| Q1 2021 | $226,000 | -6.6% | 4,900 | 0.0% | 0.06% | -4.5% |
| Q4 2020 | $242,000 | – | 4,900 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ahrens Investment Partners LLC | 74,825 | $3,561,000 | 1.91% |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 40,961 | $1,174,000 | 0.99% |
| Diversified, LLC | 19,077 | $818,000 | 0.70% |
| CORRADO ADVISORS, LLC | 9,645 | $459,000 | 0.35% |
| Rikoon Group, LLC | 16,672 | $793,000 | 0.22% |
| Eudaimonia Partners, LLC | 8,240 | $392,000 | 0.09% |
| Arete Wealth Advisors, LLC | 10,658 | $507,000 | 0.07% |
| SOA Wealth Advisors, LLC. | 4,900 | $242,000 | 0.07% |
| Financial Advantage, Inc. | 833 | $39,000 | 0.04% |
| Jacobi Capital Management LLC | 4,184 | $199,000 | 0.03% |